Atai Life Sciences N.V. (ATAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 0 | 230 | 266 | 0 | 19,880 |
| Gross Profit | N/A | 230 | 266 | N/A | 19,880 |
| Operating Expenses | 33,442 | 45,405 | 33,627 | 61,319 | 15,830 |
| Operating Income | -33,442 | -45,175 | -33,361 | -61,319 | 4,050 |
| Other Income | -4,075 | -52,519 | 2,087 | 8,004 | 0 |
| Pre-tax Income | -37,517 | -97,694 | -31,274 | -53,315 | 4,050 |
| Income Tax | 41 | -4,421 | 368 | 58 | 6 |
| Net Income Continuous | -37,558 | -93,273 | -31,642 | -53,373 | 4,044 |
| Minority Interests | -689 | -4,396 | -484 | -4,912 | 3,356 |
| Net Income | $-36,869 | $-88,877 | $-31,158 | $-48,461 | $688 |
| EPS Basic Total Ops | -0.24 | -0.64 | -0.21 | -0.37 | 0.01 |
| EPS Basic Continuous Ops | -0.24 | -0.68 | -0.21 | -0.40 | 0.03 |
| EPS Diluted Total Ops | -0.24 | -0.64 | -0.21 | -0.37 | 0.01 |
| EPS Diluted Continuous Ops | -0.24 | -0.68 | -0.21 | -0.40 | 0.03 |
| EBITDA(a) | $-33,382 | $-45,146 | $-33,368 | $-61,300 | $4,056 |